Clinical experience with non‐invasive prenatal screening for single‐gene disorders

OBJECTIVE: To assess the performance of a non‐invasive prenatal screening test (NIPT) for a panel of dominant single‐gene disorders (SGD) with a combined population incidence of 1 in 600. METHODS: Cell‐free fetal DNA isolated from maternal plasma samples accessioned from 14 April 2017 to 27 November...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, P., Lemoine, J., Trotter, C., Rakova, I., Billings, P., Peacock, S., Kao, C.‐Y., Wang, Y., Xia, F., Eng, C. M., Benn, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302116/
https://www.ncbi.nlm.nih.gov/pubmed/34358384
http://dx.doi.org/10.1002/uog.23756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302116/
https://www.ncbi.nlm.nih.gov/pubmed/34358384
http://dx.doi.org/10.1002/uog.23756

Ejemplares similares